BioEclipse Therapeutics

Privately held: no public share price

Assets

(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
6Diseases
Quick filter:
Showing 1 of 1 assets
Target & Modality
Phase 1
Cell-based oncolytic virus immunotherapyCell therapy
Non-Small Cell Lung CancerOvarian CancerHepatocellular CarcinomaColorectal CancerGastric CancerMelanoma

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

No financial reports recorded.